Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
........ for killing the mole
Hoosier,
You lack common sense. Sometimes you have to play it smart and work with them because you had no sensible solution and that was proven in the RNS.
'Sometimes you have to play it smart'
Ramping all the way down from 60p is 100% smart; well done you.
Not me who made the decisions. The company is worth 10/20 times where we are. It is a mess created by others with BOD against shareholders.
Listen to the song, always look on the bright side of life.......
There are people pushing up daisys would love this problem......
Ps. What Dopet c * * t s - listened to and saw Susys CV and though any different FFS
Pm ,
The company worth nothing with wrong people in charge .
Valrix company will go bust 100% . Stop ramping company that will no longer survive in future . You are only hoping people will buy lot share at this level so you and ice can benefit from rise before it goes bust.๐๐ผ๐๐ผ๐๐ผ๐๐ผ
Not really. No point me selling at this price because . We will get a new CEO and things will change hopefully for the better not that I agree with the approach. More likely to get a takeover if they cannot get it up than bust as plenty of time still left.
News is still due and given the market cap plenty of time to get this up.
Officially we have until the end of Q1 2025 so that is a long time. Over reaction and a good buy in my view as any news from here could be significant.
Cash runway now appears sufficient to carry it well into 2025
Full year 2023E Group net losses along with the cost of establishing/facilitating Inaphaea Biolabs (including the
acquisition of Imagen Therapeutics), resulted in an average estimated cash burn of a little over ยฃ200,000/month for
the period. If one now prudently assumes further, albeit somewhat reduced, Group net losses for 2024E, during
which time it utilises the newly raised net funding to accelerate exploitation and integration of its acquired BioBank
materials in tandem with commercial development/brand establishment within Inaphaea while also advancing
its preclinical product pipeline in the absence of further cash acquisition(s), the Group now appears to have runway
sufficient to carry it into Q2 2025.
Between now and then, of course, various upside scenarios suggest this period could become significantly extended.
This could be derived through securing higher volumes of fee-paying service customers for Inaphaea, potential
signing of licensing agreements with external parties willing to pay upfront charges and fund ongoing
development of the Groupโs preclinical and/or clinical assets which, in turn, could also attract continuing
milestones instalments. Any such outcome could be both transformative for ValiRxโs balance sheet while also
proving its business model.
Are you Suzy or Kevin PM? Never seen anyone with such rose tinted glasses in my life. You were the musicians still playing as the titanic went down reincarnate.
Pm ,
Who is going to pay Poxy company called Valrix to take over ??? You are mad .
Hoosier,
You did exactly what you were told and look what happened?
Learn to think for yourself.
I have to agree with you one one comment of yours PM - 'any news from here could be significant.'
I bailed at 4p. Yet, here you are and everything is fine and Suzy's done and is doing a stella (Pardon the pun) job and as you say, dont panic you will be 10/20/50 times where you are now in no time at all. This is just a hiccup as investors stuck their noses in to change things. Loser.
I also got out a while back and used what was left to top up my state pension. No massive deal to make me rich but at least I will get a return. Good luck all who are left.